🔍

CAS Number: 107753-78-6

Zafirlukast

Zafirlukast

Avin India is the Global sourcing company who engaged in supplying and marketing of Active Pharmaceutical Ingredient API, Zafirlukast CAS No.107753-78-6 from India and to other countries.

We supply Zafirlukast CAS No.107753-78-6 from our sources, for customers Product development and commercialization needs, depending on availability from our Indian and international sources.

We can also supply Zafirlukast CAS No.107753-78-6 Intermediates also. We meet our customers’ regulatory compliance and specifications needs and providing APIs and intermediates in a timely manner, as well as we have good relations with manufacturers or suppliers for timely delivery who produce high-quality goods.

We also assure Zafirlukast CAS No.107753-78-6 Active Pharmaceutical Ingredient is manufactured by GMP compliant facility. We can provide from small R&D to commercial Quantity Zafirlukast CAS No.107753-78-6. With documentation support DMF (OPEN PART), DMF (CLOSED PART) CEP / COS etc. from our manufacturers/Principals.

In case you are searching for a reliable source of Active Pharmaceutical Ingredients –API, Zafirlukast CAS No.107753-78-6 Please send us your sourcing requests, Email or call us for the same. We look forward for further communication of your sourcing requirement.

CAS Number: 107753-78-6

Molecular Formula: C31H33N3O6S

Molecular Weight: 575.68

Packing: All types of export worthy packings available

Synonyms: [3-[[2-Methoxy-4-[[[(2-methylphenyl)sulfonyl]amino]carbonyl]phenyl]methyl]-1-methyl-1H-indol-5-yl]carbamic Acid Cyclopentyl Ester, ICI-2204219, Accolate;Carbamic acid, [3-[[2-methoxy-4-[[[(2-methylphenyl)sulfonyl]amino]carbonyl]phenyl]methyl]-1-methyl-1H-indol-5-yl]-, cyclopentyl ester;Cyclopentyl 3-[2-methoxy-4-[(o-tolylsulfonyl)carbamoyl]benzyl]-1-methylindole-5-carbamate;[3-[[2-Methoxy-4-[[[(2-methylphenyl)sulfonyl]amino]carbonyl]phenyl]methyl]-1-methyl-1H-indol-5-yl]carbamic acid cyclopentyl ester;4-[5-(Cyclopentyloxycarbonylamino)-1-methyl-1H-indol-3-ylmethyl]-3-methoxy-N-(2-methylphenylsulfonyl)benzamide;IC-204219;Carbamic acid, N-[3-[[2-methoxy-4-[[[(2-methylphenyl)sulfonyl]amino]carbonyl]phenyl]methyl]-1-methyl-1H-indol-5-yl]-, cyclopentyl ester;cyclopentyl N-{3-[(2-Methoxy-4-{[(2-Methylbenzene)sulfonyl]carbaMoyl}phenyl)Methyl]-1-Methyl-1H-indol-5-yl}carbaMate

Pharmacopeia: IP/BP/EP/JP/USP

Specification: Click Here

Documents for regulatory, semi-regulatory and non-regulatory markets: DMF (open part), DMF (closed part), CEP/COS, cEUGMP, cGMP, USFDA, GMP, Halal-Kosher, Korea FDA, USDMF, EDMF, Canadian DMF, TDMF, KDMF, JDMF, COS, COPP, Tech Pack etc.

Note: The above pharmacopeia and the documents depends upon the manufacturer and may vary strictly as per the availability.

Enquire Now

Share this product on

Disclaimer:-

  • Patent Infringement Policy: Avin India requests buyers not to procure any items in order to create a product that may be intentionally violating intellectual property in any way, along with any individual’s patent rights. Products covered by valid patents are not presented for sale in countries, where doing so would be considered patent infringement, and the buyer would be liable. In accordance with 35 USC 271 (e) +A13, products currently covered by valid US patents are given for R&D usage. For more details click here
  • Controlled Substance Policy: Only the original import license issued by the authorities of the importing country is mandatory, for products included in the controlled substance category of scheduled products to be exported directly from the manufacturer end. For more details click here

Want me to call you back? :)